FSIS has released a generic hazard analysis and critical control point (HACCP) model for raw non-intact egg products.

This guidance document, which has been issued to increase the supply of infant formula, will remain in effect until November 14, 2022, at which time the FDA will evaluate whether any extension is necessary.

In a Constituent Update released today, the FDA has made available testing results for per- and polyfluoroalkyl substances (PFAS) in seafood samples collected at retail. 

When finalized, the FDA’s guidance will outline its approach to the public health importance of food allergens that are not one of the major nine food allergens identified by law in the U.S.

The FDA is conducting the consumer research on a potential symbol, which is intended to be a stylized representation of the nutrient content claim “healthy.” 

The intention is to reduce the potential for negative health effects from dietary exposure to lead.

The FDA has finalized guidance to help companies prepare to quickly and effectively remove violative products from the market.

The U.S. Food and Drug Administration issued a final guidance titled “Reconditioning Fish and Fishery Products by Segregation: Guidance for Industry.” 

The Interagency Food Safety Analytics Collaboration (IFSAC)—a collaboration between the CDC, FDA and FSIS—has published its priorities for this year and next.

The FDA is asking establishments currently exporting certain food products to China to voluntarily submit information.